P 125 (Everolimus 5 mg)
Pill with imprint P 125 is White, Capsule-shape and has been identified as Everolimus 5 mg. It is supplied by Par Pharmaceutical, Inc..
Everolimus is used in the treatment of neuroendocrine carcinoma; breast cancer; organ transplant, rejection prophylaxis; pancreatic cancer; renal angiomyolipoma and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Everolimus 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for P 125
Everolimus
- Imprint
- P 125
- Strength
- 5 mg
- Color
- White
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Mtor inhibitors, Selective immunosuppressants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Par Pharmaceutical, Inc.
- National Drug Code (NDC)
- 49884-0125
Related Images for "P 125"
More about everolimus
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 23 Reviews
- Drug class: mTOR inhibitors
Consumer resources
- Patient Information
- Everolimus (Advanced Reading)
- Everolimus Tablets (Afinitor)
- Everolimus Tablets (Zortress)
- Everolimus Tablets For Oral Suspension
- Other brands
- Afinitor, Zortress, Afinitor Disperz
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.